Literature DB >> 9122620

Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease.

K S Price1, F P Nestel, W S Lapp.   

Abstract

In a previous report the authors demonstrated that acute graft-versus-host disease (GVHD) was associated with pathologic amounts of tumour necrosis factor alpha (TNF-alpha) and the appearance of lipopolysaccharide (LPS) in the blood of GVH reactive mice just prior to death. In this study the authors have investigated the kinetics of LPS accumulation in different organs during the course of acute GVHD using a murine model. Unirradiated C57BL/6 x AF1 (B6AF(1)) mice were transplanted with C57BL/6 (B6) lymphoid cells and killed at predetermined times after transplantation for LPS analysis. Control animals were injected with either 60 x 10(6) B6AF1 lymphoid cells (syngeneic) or 60 x 10(6) irradiated (2000 rad) CBA lymphoid cells (allogeneic). Lipopolysaccharide began to appear in the liver and the spleen of GVH reactive mice from day 2 post-transplant and by day 10 all GVH reactive mice tested positive for hepatic and splenic LPS. Low levels of LPS were detected in some control mice from days 2 to 10 post-transplant but LPS was never detected after day 10 in control groups. Total hepatic and splenic LPS in acute GVH reactive mice peaked at a time coincident with the appearance of LPS in the serum and with the onset of mortality. These results demonstrate that tissue levels of LPS increase throughout the course of acute GVHD and are sufficient to trigger the release of pathologic amounts of TNF-alpha from primed macrophages resulting in the cachexia and mortality associated with acute GVHD in this model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122620     DOI: 10.1046/j.1365-3083.1997.d01-404.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  The pathophysiology of acute graft-versus-host disease.

Authors:  James L M Ferrara; Kenneth R Cooke; Takanori Teshima
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

3.  Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells.

Authors:  Dennis B Leveson-Gower; Emanuela I Sega; Janet Kalesnikoff; Mareike Florek; Yuqiong Pan; Antonio Pierini; Stephen J Galli; Robert S Negrin
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

4.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

Authors:  K R Cooke; G R Hill; J M Crawford; D Bungard; Y S Brinson; J Delmonte; J L Ferrara
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

5.  Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen.

Authors:  Cynthia A Ellison; Shannon A Natuik; Jacqie M M Fischer; Alan R McIntosh; Sheila A Scully; Eric J Bow; Dimitry M Danilenko; Kent T Hayglass; John G Gartner
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

6.  The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice.

Authors:  Cynthia A Ellison; Shannon A Natuik; Alan R McIntosh; Sheila A Scully; Dimitry M Danilenko; John G Gartner
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

7.  High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation.

Authors:  Cécile Chagué; Thomas Gautier; Ludivine Dal Zuffo; Jean-Paul Pais de Barros; Audrey Wetzel; Georges Tarris; Gaëtan Pallot; Laurent Martin; Séverine Valmary-Degano; Valérie Deckert; Laurent Lagrost; Etienne Daguindau; Philippe Saas
Journal:  Am J Transplant       Date:  2022-02-10       Impact factor: 9.369

8.  Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance.

Authors:  Larissa Hering; Egle Katkeviciute; Marlene Schwarzfischer; Philipp Busenhart; Claudia Gottier; Dunja Mrdjen; Juliana Komuczki; Marcin Wawrzyniak; Silvia Lang; Kirstin Atrott; Burkhard Becher; Gerhard Rogler; Michael Scharl; Marianne R Spalinger
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.